Fundamentals of Disinfectant Efficacy
Disinfectants must be qualified on the surfaces present within a pharmaceutical manufacturing environment before they are approved for use in the facility. Designing a study with robust parameters, including information from in-house environmental monitor programs and avoiding common pitfalls is essential to prevent negative feedback from regulatory agencies. Investing time in thoughtful study design and development at the outset can ultimately save significant resources and effort. This presentation aims to outline the objectives of disinfectant efficacy testing and its relationship to in-house environmental monitoring programs, while emphasizing practical guidance on developing methodology for designing coupon studies that accurately represent facility procedures and needs. Additionally, we will discuss how the results of a coupon study can be leveraged to enhance and strengthen contamination control strategies. Key takeaways: • How to choose parameters that are representative of your facility and meet regulatory expectations. o How environmental monitoring programs assist in determining testing scope. • Indications that initial or subsequent disinfectant efficacy testing is required. • Obtaining microorganism log reductions and translating into useful information on the efficacy of facility cleaning procedures and disinfectants.

Ensuring Drug–Device Compatibility: Foundations for Safe and Effective Combination Products

Shared Momentum: Turning Efficiency Insights into Building Value

Fire Code Changes for Ontario Specimen Storage Facilities

From Imaging to Decision: Improving Nonmalignant Asbestos Health Screening with Evidence from Libby

Discover Healthier Flooring Options through the MRO001 Statewide Contract

Always Inspection-Ready: Mastering FDA Inspection Preparation and Response

Ukraine's drone war is isolating Crimea

A Day in the Life of a Stewardship Champion.

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

Environmental Monitoring (EM)

Building the Antimicrobial Stewardship Team.

Endotoxin Retention Testing for Filters

How to Address These Updates for Existing Products and In-Process Submissions

But what is quantum computing? (Grover's Algorithm)

Fire Code Shake-Up: Is Your Lab Ready?

How ASML Makes Chips Faster With Its New $400 Million High NA Machine

Antineoplastic Agents | Clinical Medicine

Accelerating Product Release Through Patent-Pending RapidCert™ (BI) Sterility Testing

Accelerating Product Release Through Patent-Pending RapidCert™ (BI) Sterility Testing

